Abstract:
Objective To investigate the 18F-fluorodeoxyglucose (FDG) PET/CT imaging characteristics of pulmonary cryptococcosis (PC).
Methods A retrospective study was performed in 22 patients with PC (17 male and 5 female; aged 54.77±7.93 years), confirmed through etiology or pathological examination from January 2011 to January 2017 in Fujian Provincial Cancer Hospital. 18F-FDG PET/CT was performed. The number, size, distribution, maximum standardized uptake value (SUVmax), and nodule sign of the nodules were analyzed. T test or Pearson correlation analysis was used in the comparison in measurement data. The differences in nodule signs among the different groups were determined by χ2 test, continuous correction χ2 test, or Fisher exact probability method.
Results ① A total of 235 nodules were found by 18F-FDG PET/CT imaging in the 22 cases of PC patients with the diameter of (0.7±0.5) cm. Of these nodules, 130 showed high 18F-FDG metabolism with an SUVmax of (3.5±2.9) and a diameter of (0.9±0.5) cm. A positive correlation was found between the two (r=0.702, P=0.000). Meanwhile, 105 nodules showed no 18F-FDG metabolism with a diameter of (0.3±0.1) cm. The diameter in the group with high 18F-FDG metabolism was greater than that in the group without 18F-FDG metabolism, and the difference was statistically significant (t=13.621, P=0.000). ② The nodules were mainly found in the right lung (57.4%, 135/235), lower lobe (64.3%, 151/235), and outer zone or subpleura (80.0%, 188/235). ③ The SUVmax in the nine cases of immunocompromised host with high 18F-FDG metabolism was 5.7±4.7 higher than that in the 13 cases of non-immunocompromised host (SUVmax was 3.0±2.0), and the difference was statistically significant (t=2.731, P=0.011). The ratio of wide base posted to the pleural sign was 17.5 (10/57) of the former and higher the 6.2% (11/178) of the latter. The ratio of halo sign was 25.3% (45/178) in the latter and higher than the former of 10.5% (6/57). All the differences were statistically significant (χ2=7.911, 4.628; P=0.005, 0.031). ④ The nodules of the group with high 18F-FDG metabolism accounted for 80% (16/20) and 53% (114/215), respectively, in the each of 11 cases of one lobe or multiple lobar involvement patients. The former SUVmax was 5.6±3.4 and higher than the latter of 3.2±2.7. The difference was statistically significant (t=2.652, P=0.016). The lobulation sign (35%, 7/20), spicule sign (30%, 6/20), and pleural indentation sign (15%, 3/20) in the former were higher than the 3.3% (7/215), 0.9% (2/215) and 0.9% (2/215) in the latter, respectively. The difference was statistically significant (χ2=32.911, 47.022, 17.395, all P<0.01). ⑤ The SUVmax of the 21 nodules with high 18F-FDG metabolism in the 44 nodules found in the 11 misdiagnosed cases was 5.0±4.6, which was higher than 3.2±2.4 in the 11 other correctly diagnosed cases where 191 nodules were found, including 109 nodules with high 18F-FDG metabolism. The difference was not statistically significant (t=16.825, P=0.106). The lobulation sign, spicule sign and pleural indentation sign in the former were 15.9% (7/44), 18.2% (8/44), 6.8% (3/44) respectively, which are higher than the 3.7% (7/191), 0.0% (0/191), and 1.0% (2/191) in the latter. The difference was statistically significant (χ2=9.570, 35.951, 5.720; all P<0.05). The halo sign was 26.2% (50/191) in the latter, and higher than the 2.3% (1/44) in the former. The difference was statistically significant (χ2=12.027, P=0.000).
Conclusions The SUVmax of the nodules is positively correlated with diameter in cases of PC by 18F-FDG PET/CT imaging. Halo sign is a reliable sign of diagnosis. The resembling tumor signs and the high 18F-FDG metabolism, caused the 18F-FDG PET/CT imaging to misdiagnose easily in patients of PC with single lobe involvment.